MAB1628
Anti-Myosin Antibody, slow muscle, clone NOQ7.5.4D
clone NOQ7.5.4D, Chemicon®, from mouse
Sign Into View Organizational & Contract Pricing
All Photos(1)
Anti-CMD1S, Anti-CMH1, Anti-MPD1, Anti-MYHCB, Anti-SPMD, Anti-SPMM
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
NOQ7.5.4D, monoclonal
species reactivity
rat, feline, human
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable
radioimmunoassay: suitable
western blot: suitable
isotype
IgG
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... MYH7B(57644)
Specificity
Slow myosin heavy chain. Clearly identifies Type 1 fibers. Within skeletal muscle MAB1628 is specific for slow myosin heavy chain in a wide variety of species. It reacts strongly with rat and feline slow myosin heavy chain. MAB1628 also identifies beta (slow) myosin heavy chain in heart ventricles.
Immunogen
Epitope: slow muscle
Myosin purified from myofibrils isolated from histochemically mixed human skeletal muscle.
Application
Anti-Myosin Antibody, slow muscle, clone NOQ7.5.4D is an antibody against Myosin for use in RIA, WB, IH.
Immunohistochemistry: frozen and formalin fixed sections.
Immunoblotting
RIA
Optimal working dilutions must be determined by end user.
Immunoblotting
RIA
Optimal working dilutions must be determined by end user.
Physical form
Format: Purified
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
recommended
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Journal of applied physiology (Bethesda, Md. : 1985), 121(3), 646-660 (2016-07-23)
Muscle loss occurs following injury and immobilization in adulthood and childhood, which impairs the rehabilitation process; however, far fewer studies have been conducted analyzing atrophic response in infants. This work investigated first the morphological and molecular mechanisms involved in immobilization-induced
Lipid in skeletal muscle myotubes is associated to the donors' insulin sensitivity and physical activity phenotypes.
Obesity (Silver Spring, Md.) null
Scientific reports, 8(1), 9814-9814 (2018-07-01)
Once assumed only to be a waste product of anaerobe glycolytic activity, lactate is now recognized as an energy source in skeletal muscles. While lactate metabolism has been extensively studied in vivo, underlying cellular processes are poorly described. This study
Investigative ophthalmology & visual science, 51(1), 192-200 (2009-08-08)
Extraocular muscle (EOM) has a distinct skeletal muscle phenotype. The hypothesis for the study was that fibroblasts support the unique EOM phenotype and that perimysial fibroblasts derived from EOM have properties that distinguish them from fibroblasts derived from other skeletal
Obesity (Silver Spring, Md.), 23(12), 2414-2420 (2015-11-06)
The purpose of the study was to determine the effects of passaging on retention of donor phenotypic characteristics in primary human myotubes. Primary muscle cultures and serial passaged myotubes from physically active, sedentary lean, and individuals with type 2 diabetes
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service